Vaximm

Developing active immunotherapies (vaccines) for patients suffering from cancer.

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2008 groups7 employees language vaximm.com

Social engagement

Social engagement: 981 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Recent activity

10 Apr 2026
Partnership
OSR Holdings
Coming soon